Answer
No. It is endocrine therapy that blocks and degrades oestrogen receptors in ER-positive cancer cells.
Sources for this answer
- Inluriyo 200 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.